Trials / Completed
CompletedNCT06090136
Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects
A Study Evaluating Safety and Pharmacokinetics of a Single Oral TPN171H in Elderly Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Vigonvita Life Sciences · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
It is a single-center, open-label, Phase I clinical study evaluating the safety and pharmacokinetics of a single oral TPN171H in elderly subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TPN171H | 5 mg TPN171H tablets，single dose,oral |
Timeline
- Start date
- 2020-09-14
- Primary completion
- 2020-12-14
- Completion
- 2022-07-22
- First posted
- 2023-10-19
- Last updated
- 2023-10-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06090136. Inclusion in this directory is not an endorsement.